Manufacturer

Thermo Fisher Scientific (China) Co., Ltd.

Address: Building 3, 6, and 7, No. 27, Xinjinqiao Road, Pudong New District, Shanghai

Company website: http://www.thermofisher.com/cn/zh/home.html

Company Overview

Thermo Fisher Scientific is a world leader in scientific services, with annual sales exceeding $30 billion. The company's mission is to help customers make the world healthier, cleaner and safer. Help customers accelerate research in the field of life sciences, solve complex problems and challenges encountered in the field of analysis, promote the development of medical diagnosis and treatment, and improve laboratory productivity. More than 80,000 Thermo Fisher employees around the world will use a series of industry-leading brands such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon to provide customers with advanced innovative technologies, convenient procurement solutions and all-round services. Thermo Fisher Scientific China In 1982, Thermo Fisher established its first sales office in China. Its headquarters in China is located in Shanghai, and it has established branches in Beijing, Guangzhou, Hong Kong, Chengdu, Shenyang, Xi'an, Nanjing, Wuhan, Jinan, Dongguan and other places. Products mainly include analytical instruments, laboratory equipment, reagents, consumables and software, providing comprehensive laboratory solutions to serve customers from all walks of life. In order to meet the needs of the Chinese market, there are currently 8 factories operating in Shanghai, Beijing, Suzhou and Guangzhou. Six application development centers and demonstration laboratories have also been established across the country to bring the world's cutting-edge technologies and products to Chinese customers, and provide a variety of services such as application development and training; the China Innovation Centers located in Shanghai and Suzhou have more than 100 professional researchers and engineers and more than 100 patents. The Innovation Center focuses on product research and development in vertical markets, combining the needs of the Chinese market with advanced technologies at home and abroad to develop technologies and products suitable for Chinese users.

Glaxo Life Sciences (Shanghai) Co., Ltd.

Address: Room A-738, 739, No. 188, Yesheng Road, Lingang New Area, Shanghai Pilot Free Trade Zone

Company website: https://www.cytivalifesciences.com.cn/

Company Overview

Cytiva is a global technology and services provider committed to advancing unseen technologies and accelerating extraordinary therapies. With a rich history dating back hundreds of years, Cytiva began a new journey in 2020 as an independent company under the Danaher Group. From basic biological research to the development of innovative vaccines, from biopharmaceuticals to the development of new cell and gene therapies, Cytiva's customers are engaged in work that is closely related to life. Cytiva's products and services provide strong support for customers to help them accelerate research, reduce costs and increase efficiency, thereby benefiting patients around the world. In 2020, most monoclonal antibodies approved by the U.S. Food and Drug Administration used Cytiva technology in their production process. Cytiva is proud of this and will continue to develop stable and reliable solutions to help more life-saving therapies. Through reproducible modern bioprocessing technologies and cell and gene therapy facilities, Cytiva provides you with the tools and expertise to advance research and introduce key therapies into the clinic. Cytiva provides a steady stream of products to support the production process of approved and registered biopharmaceuticals (including cell and gene therapies). Cytiva always practices the concept of sustainable development and truly meets the needs of current patients without sacrificing the interests of future generations.

AIBEND (SHANGHAI) INTERNATIONAL TRADE CO., LTD.

Address: 10th Floor, Century Trade Plaza, No. 989 Changle Road, Xuhui District, Shanghai

Company website: https://www.eppendorf.com/CN-zh/

Company Overview

Eppendorf is a cutting-edge life science company that focuses on the development and sales of laboratory liquid handling, sample handling and cell handling instruments, consumables and services. The main products include pipettes, automatic pipetting systems, dispensers, centrifuges, mixers, spectrophotometers and DNA amplification instruments, as well as ultra-low temperature refrigerators, fermenters, bioreactors, CO2 incubators, biological shakers and cell micromanipulation systems. Consumables include high-performance and high-quality products such as pipette tips, centrifuge tubes, PCR plates, microplates and disposable bioreactor tanks. Eppendorf's products are widely used in scientific research and commercial R&D laboratories, such as pharmaceutical and biotechnology, chemical and food industries. In addition, the company's products are also widely used by clinical and environmental analysis laboratories, forensic and industrial users in process analysis, production and quality testing. Founded in 1945, Eppendorf is headquartered in Hamburg, Germany, and currently has about 4,500 employees worldwide. The company has subsidiaries in 28 countries and distributors in relevant important market areas around the world.

ABEC Corporation

Address: USA

Company website: https://cn.abec.com/

Company Overview

Since its establishment in 1974, ABEC has been a leader in providing overall solutions and services for the biopharmaceutical industry. Most of the global pharmaceutical and biotech companies are ABEC's customers, and many of today's mainstream drugs are produced by equipment designed, manufactured, installed and serviced by ABEC. Rich experience, complete internal strength, customer customization, flexible methods, and trustworthiness have made ABEC unique in the industry. Whether it is expanding production capacity or upgrading existing equipment, ABEC's turnkey solutions and support can reduce total costs and shorten time to market while ensuring production capacity. ABEC provides the industry's largest global biopharmaceutical equipment manufacturing capacity. ABEC's equipment manufacturing plant has a total area of nearly 32,000m² and two ISO-7 clean rooms, with strong equipment construction capabilities and complex factory acceptance testing (FAT) large system configurations. ABEC is committed to supporting the growing biopharmaceutical manufacturing industry and continues to reinvest and expand its capabilities and capacity. Founded in the early days of the biotechnology era, ABEC has always been an innovative leader in bioprocess engineering and equipment design. Prior to the 1990s, ABEC made numerous improvements in system design, materials and surface treatment, CIP/SIP integration, aseptic mixer seals, sanitary component design, mixing and mass transfer, documentation and automation. Since then, ABEC's leadership in innovation has continued with the further development of products, services and global infrastructure, and strategic investments have reshaped ABEC's ability to provide overall bioprocessing solutions and services worldwide. For more than 40 years, ABEC has been at the forefront of innovation in biopharmaceutical production technology, providing key equipment and services to help customers reach higher levels of productivity. Pharmaceutical companies around the world use ABEC to help deliver "life-changing" drugs. In everything ABEC does, it is committed to providing high-quality products and services to enable customer success, which is also the value of ABEC.

Merck Investment (China) Co., Ltd.

Address: 16th Floor, Building C, Qiantan World Trade Center (Phase II), No. 3, Lane 227, Dongyu Road, Pudong New District, Shanghai

Company Overview

Merck KGaA was founded in 1668 and has a history of about 350 years. Headquartered in Darmstadt, Germany, the group is mainly committed to innovative pharmaceuticals, life sciences and cutting-edge functional materials technologies, and uses technology as a driving force to create value for patients and customers. Merck began to engage in trade activities with China in the late 19th century, selling high-purity chemical reagents to China, and established a Chinese subsidiary in Shanghai in 1933. In China, Merck is mainly engaged in pharmaceutical, life science and chemical businesses, and provides customers with solutions ranging from innovative prescription drugs, over-the-counter drugs to life sciences, and effect pigments and chemicals for industrial use. Merck's business is mainly divided into four major branches: Merck Serono Business Branch, Consumer Healthcare Business Branch, Merck Millipore Business Branch, and Functional Materials Business Branch. Merck is a partner of China. Merck has a history of more than 80 years of development in China. China is an important strategic market for all Merck business areas (including high-performance materials, life sciences and healthcare); Merck has 3,200 employees in China (including Hong Kong and Macau); and 20 corporate entities in Beijing, Shanghai, Hong Kong, Wuxi, Suzhou and Nantong. Merck has many important investments in China. Recently, Merck has invested 170 million euros, 80 million euros and 44 million euros in its healthcare and life sciences businesses in Nantong and its high-performance materials business in Shanghai, respectively. In addition, Merck has established a global biopharmaceutical R&D center in Beijing, a display materials R&D center and a life science laboratory in Shanghai, and a lithography materials R&D center in Suzhou. China has become an important source of innovation for Merck.

Pall (China) Co., Ltd.

Address: No. 12, Hongda South Road, Beijing Economic and Technological Development Zone

Company website: https://www.pall.cn/

Company Overview

Pall Corporation is an operating company of the Life Sciences platform of Danaher Corporation (NYSE: DHR). Pall's global employees are committed to solving customers' challenges in filtration, separation and purification, and promoting the advancement of health, safety and environmental technology. Pall provides a wide range of technologies and solutions to protect health, protect key operating assets, improve product quality, and reduce emissions and waste. Pall's Life Sciences and Industrial teams specialize in serving a wide range of customers in various industries, including biotechnology, pharmaceuticals, medical, food and beverage, laboratories, microelectronics, aerospace, fuel petrochemicals, chemicals, automobiles and power. Pall (China) Co., Ltd. is a wholly-owned enterprise of Pall Group in China. After more than 20 years of development in China, it has developed from a company focusing on filtration products to an expert in filtration, separation and purification solutions. From upstream R&D to large-scale production, from pre-sales technical support to after-sales service, from product sales to providing overall solutions, Pall not only provides customers with high-tech products and applications, but also plays a pioneering role in technology and innovative quality. From biotechnology concept to design, biotechnology validation and production for all biotechnology applications, Pall offers innovative technologies and solutions that can help you adapt to the changing market needs. Whether that means developing new drug processes, helping you ensure regulatory compliance, or simplifying, accelerating and improving existing processes, Pall is ready to work with you to meet the needs of biotechnology. Pall biotechnology products play a key development and manufacturing role in life-saving medicines, from Ebola vaccines to monoclonal antibodies for cancer treatment. Pall's biotechnology portfolio is suitable for integrated systems, which can reduce total cost of ownership by improving process economics. Whether targeting clinical or full production scale, customers can reduce their total cost of ownership when they work with suppliers who can adapt to the unique challenges they face. Pall provides complete biotechnology coverage from cell culture to formulation filling. Pall's biotechnology portfolio helps produce life-improving medicines at a lower upfront cost. Just like the biotechnology industry itself, Pall is constantly innovating. For example, Pall's continuous process technology enables true continuous manufacturing. The award-winning Cadence Inline Concentrator (ILC), a key downstream processing (DSP) product, continuously concentrates products, reduces shear damage, shortens process time and improves quality. Pall's disruptive Cadence acoustic separator, combined with a polishing depth filter, continuously removes cells and cell debris from cell culture fluids in a closed system without the need for centrifugation or prior depth filtration. It reduces the use of depth filters and buffers and provides consistent solids removal. Pall will continue to evolve as the biotech market changes. The rise of single-use facilities, process intensification, integrated unit operations and continuous processing continues to improve facility efficiency and flexibility while reducing footprint and shortening process time. Pall offers a bioprocessing portfolio that supports upstream to downstream and fill and finish stages. This single-use, multi-solution is the end-to-end solution needed by biotech manufacturers to help seek validated solutions and ensure scalable supply chain security.